Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment | Zendy

Morton Leibowitz | Zendy; Tomas Karpati | Zendy; Chandra J. Cohen-Stavi | Zendy; Becca Feldman | Zendy; Moshe Hoshen | Zendy; Haim Bitterman | Zendy; Samy Suissa | Zendy; Ran D. Balicer | Zendy

Open Access

Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment

Author(s) -

Morton Leibowitz,

Tomas Karpati,

Chandra J. Cohen-Stavi,

Becca Feldman,

Moshe Hoshen,

Haim Bitterman,

Samy Suissa,

Ran D. Balicer

Publication year - 2016

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2016.2751

Subject(s) - medicine , hazard ratio , myocardial infarction , statin , cardiology , propensity score matching , proportional hazards model , unstable angina , population , adverse effect , cohort , stroke (engine) , confidence interval , mechanical engineering , environmental health , engineering

International guidelines recommend treatment with statins for patients with preexisting ischemic heart disease to prevent additional cardiovascular events but differ regarding target levels of low-density lipoprotein cholesterol (LDL-C). Trial data on this question are inconclusive and observational data are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research